|
|||||||||||||||
|
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016 Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) |
||||||||||||||
Issue: May 2024
Volume 9 | Issue 5
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.76
Issue per Year : 12
Volume Published : 9
Issue Published : 96
Article Submitted :
Article Published :
Total Authors :
Total Reviewer :
Total Countries :
Indexing Partner
Join RMS/Earn 300
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | SGLT2 Inhibitors as Pioneering Solutions in Diabetes Care - A Comprehensive Review |
| Authors Name: | Ayesha praveen , Chirag chandel , Ashish kardwal |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJNRD_218903
|
| Published Paper Id: | IJNRD2404539 |
| Published In: | Volume 9 Issue 4, April-2024 |
| DOI: | |
| Abstract: | Plants play an important role in human existence; they are used as firewood, timber, fibres, fruitsand vegetables, and to make paper, cloth, rope, dyes, pesticides, etc. Besides as a source of food, they are an important source of medicine. Worldwide, the plants and their derived products are used for the treatment of health issues such as diabetes, cancer, hypertension, malaria, inflammation, and nervous disorders, etc. in different conventional as well as modern systems of medicine. Diabetes, a chronic metabolic disorder with elevated blood glucose levels, causes lasting damage to vital organs. Type-2 diabetes is prevalent worldwide, affecting 422 million individuals. Its global burden, causing 1.5 million deaths annually, has risen significantly. Several approaches are currently used to control and cure diabetes by using available anti-diabetic medications in modern medicine. α-Amylase inhibitors, α-glucosidase inhibitors, biguanides, sulphonylurea, GLP-1 receptor agonists, DPP-4 inhibitors, and thiazolidinediones are examples of anti-diabetic medicines, each targeting glucose regulation through distinct mechanisms. SGLT2 inhibitors, a novel class of drugs, effectively manage diabetes by impeding renal glucose reabsorption, reducing blood glucose levels. FDA-approved, these synthetic medications mark a significant advancement in diabetes care. Despite effective strategies, there's a need for safer, more efficient treatments, emphasizing the crucial role of medicinal plants in resource-limited settings. This study presents a comprehensive review of the SGLT2 inhibitors. It encapsulates the extensive research on SGLT2 inhibitors, unveiling their promising potential as a source of natural anti-diabetic medicine. |
| Keywords: | Chronic metabolic disorder, FDA-approved medicine, Natural Products |
| Cite Article: | "SGLT2 Inhibitors as Pioneering Solutions in Diabetes Care - A Comprehensive Review", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.9, Issue 4, page no.f311-f328, April-2024, Available :http://www.ijnrd.org/papers/IJNRD2404539.pdf |
| Downloads: | 00026 |
| ISSN: |
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID:IJNRD2404539 Registration ID: 218903 Published In: Volume 9 Issue 4, April-2024 DOI (Digital Object Identifier): Page No: f311-f328 Country: Dehradun, dehradun, Uttrakhand, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2404539 Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2404539 |
| Share Article: |
|
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijnrd.org
| Semantic Scholar | Microsaoft Academic | ORCID | Zenodo |
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | PUBLON |
| DRJI | SSRN | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Social Media
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Join RMS/Earn 300
| Copyright © 2024 - All Rights Reserved - IJNRD |
Facebook Twitter Instagram LinkedIn